Nebivolol in chronic heart failure: current evidence and future perspectives

Author： Lipšic Erik van Veldhuisen Dirk J

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.6, 2010-04, pp. : 983-992

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Heart Failure: Current Evidence, Challenges to Therapy, and Future Directions

By Morrissey Ryan P. Czer Lawrence Shah Prediman K.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 3, 2011-06 ,pp. : 153-171

Adis International

Access to resources Recommend Favorite

Nebivolol for the treatment of heart failure

By Riva Nicoletta Lip Gregory YH

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1733-1746

Informa Healthcare

Access to resources Recommend Favorite

Nebivolol in Hypertension and Chronic Heart Failure: A Viewpoint by Alberto Zanchetti

By Zanchetti Alberto

Drugs, Vol. 66, Iss. 10, 2006-01 ,pp. : 1410-1410

Adis International

Access to resources Recommend Favorite

Nebivolol: A Review of its Use in the Management of Hypertension and Chronic Heart Failure

By Moen Marit D. Wagstaff Antona J.

Drugs, Vol. 66, Iss. 10, 2006-01 ,pp. : 1389-1409

Adis International

Access to resources Recommend Favorite

Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches

Current Pharmaceutical Design, Vol. 22, Iss. 31, 2016-09 ,pp. : 4807-4822

Bentham Science Publishers

Access to resources Recommend Favorite